THOMSON ROBERT C
SEC CIK 1980521 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AORT | ARTIVION, INC. | VP Research, Development | 13.3K | — | — | 2 | 2023-06-09 | 2024-02-23 |
Most active insiders at AORT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mackin James P | Pres, CEO | — | $9.72M |
| 2 | Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| 3 | Holloway Jean F | SVP, GC | — | $2.54M |
| 4 | Davis John E | Chief Commercial Off | — | $1.75M |
| 5 | GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| 6 | Horton Amy | VP, CAO | — | $870.1K |
| 7 | Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| 8 | Hoff Elizabeth A | Dir | — | $189.4K |
| 9 | SEMEDO ANTHONY B. | Dir | — | — |
| 10 | Borgstrom Marna P | Dir | — | — |
THOMSON ROBERT C made no open-market trades at AORT in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-26 | 2024-02-23 | AORT | ARTIVION, INC. | THOMSON ROBERT C | VP Research, Development | A - Grant | $0.00 | +8,165 | 13.3K | +159% | $0 | |
| D | 2023-06-12 | 2023-06-09 | AORT | ARTIVION, INC. | THOMSON ROBERT C | VP Research, Development | A - Grant | $15.49 | +5,126 | 5,126 | New | +$79.4K |
Purchase Sale Sale after option exercise All abbreviations